← Back to Search
Human Brain Cortex: Mitochondrial Oxidative Damage And Adaptive Response In Parkinson Disease And In Dementia With Lewy Bodies.
A. Navarro, A. Boveris, M. J. Bández, María-Jesús Sánchez-Pino, C. Gómez, G. Muntané, I. Ferrer
Published 2009 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Frontal cortex samples from frozen human brains were used to assess tissue respiration; content of mitochondria; mitochondrial oxygen uptake; activity of respiratory complexes and of mitochondrial nitric oxide synthase (mtNOS); content of cytochromes a, b, and c; oxidative damage (protein carbonyls and TBARS); and expression of Mn-SOD in patients with Parkinson disease (PD) and with dementia with Lewy bodies (DLB) in comparison with those of normal healthy controls. Brain cortex and mitochondrial O(2) uptake and complex I activity were significantly lower in PD and DLB, whereas mtNOS activity, cytochrome content, expression of Mn-SOD, mitochondrial mass, and oxidative damage were significantly higher in the frontal cortex in PD and DLB. The decreases in tissue and mitochondrial O(2) uptake and in complex I activity are considered the consequences of mitochondrial oxidative damage. The increases in mtNOS activity and in mitochondrial mass are interpreted as an adaptive response of the frontal cortex that involves increased NO signaling for mitochondrial biogenesis. The adaptive response would partially compensate for mitochondrial dysfunction in these neurodegenerative diseases and would afford a human evolutionary response to shortage of ATP in the frontal cortex.
This paper references
The metabolism of rat brain mitochondria. Preparation and characterization.
J. B. Clark (1970)
Reduction of mitochondrial components by durohydroquinone.
A. Boveris (1971)
Mechanisms for Intracellular Calcium Regulation in Heart I. Stopped-Flow Measurements of Ca++ Uptake by Cardiac Mitochondria
A. Scarpa (1973)
Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species.
J. M. Tolmasoff (1980)
Medicine and the Law
D. Brahams (1983)
Age-related changes in oxidized proteins.
C. Oliver (1987)
Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes.
C. Fraga (1988)
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
Y. Mizuno (1989)
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
A.H.V. Schapira (1989)
Mitochondrial Complex I Deficiency in Parkinson's Disease
A. H. V. Schapira (1989)
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease
A. Schapira (1990)
Oxygen free radicals and Parkinson's disease.
J. Adams (1991)
Antioxidants and aging.
R. Cutler (1991)
Human mitochondrial complex I dysfunction.
J. Cooper (1992)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)
I. McKeith (1996)
Neuropathology of Parkinson's Disease
L. Forno (1996)
Nitric oxide synthase activity in mitochondria
P. Ghafourifar (1997)
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
P. Ince (1998)
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
M. Baba (1998)
Production of Nitric Oxide by Mitochondria*
C. Giulivi (1998)
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
M. Spillantini (1998)
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
M. Hashimoto (1999)
Regulation of mitochondrial respiration by adenosine diphosphate, oxygen, and nitric oxide.
A. Boveris (1999)
Dementia with Lewy bodies
M. Jf (2000)
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
I.G. McKeith (2000)
Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection
A. Kanai (2001)
Dementia with Lewy bodies.
P. Ince (2001)
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
B. Giasson (2002)
Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice.
A. Navarro (2002)
Pharmacological regulation of mitochondrial nitric oxide synthase.
A. Boveris (2002)
The Modulation of Mitochondrial Nitric-oxide Synthase Activity in Rat Brain Development*
N. Riobo (2002)
Biochemistry of Mitochondrial Nitric-oxide Synthase*
S. Elfering (2002)
Aggregation of α-synuclein in the pathogenesis of Parkinson’s disease
T. Iwatsubo (2003)
Kidney mitochondrial nitric oxide synthase.
A. Boveris (2003)
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
D. W. Dickson (2003)
Mitochondrial enzyme activities as biochemical markers of aging.
A. Navarro (2004)
Rat brain and liver mitochondria develop oxidative stress and lose enzymatic activities on aging.
A. Navarro (2004)
Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease.
M. C. Carreras (2004)
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals.
E. Nisoli (2004)
Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer.
A. Navarro (2004)
Mitochondrial function and mitochondria-induced apoptosis in an overstimulated rat ovarian cycle.
A. Navarro (2005)
Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease
H. Poon (2005)
Heart mitochondrial nitric oxide synthase is upregulated in male rats exposed to high altitude (4,340 m).
G. Gonzales (2005)
Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
E. Dalfo (2005)
The role of mitochondria in inherited neurodegenerative diseases
J. Kwong (2006)
Epidemiology of Parkinson's disease
L. M. D. Lau (2006)
Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled
P. Keeney (2006)
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease
A. Bender (2006)
Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease
I. Ferrer (2007)
“Machiavellianism” and frontal dysfunction: Evidence from Parkinson's disease
P. McNamara (2007)
Nitric oxide and peroxynitrite in health and disease.
P. Pacher (2007)
The mitochondrial energy transduction system and the aging process.
A. Navarro (2007)
Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome
P. Finocchietto (2008)
Hippocampal mitochondrial dysfunction in rat aging.
A. Navarro (2008)
Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants.
A. Navarro (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
A. Schapira (2008)
Brain mitochondrial dysfunction in aging
A. Boveris (2008)
Early α-synuclein lipoxidation in neocortex in Lewy body diseases
E. Dalfo (2008)
This paper is referenced by
Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisal
Nitya Subrahmanian (2021)
Modelling Parkinson’s Disease: iPSCs towards Better Understanding of Human Pathology
S. Avazzadeh (2021)
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Manuela Gries (2021)
Title: Systematic review of gene expression studies in people with Lewy Body Dementia Short running title: Gene expression changes in Lewy Body Dementia Authors and affiliations:
Anisa Chowdhury (2020)
Systematic review of gene expression studies in people with Lewy body dementia
Anisa Chowdhury (2020)
Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease
A. Miranda-Díaz (2020)
PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson’s disease
Preston Ge (2020)
Assessment of the Effects of Aerobic Fitness on Cerebrovascular Function in Young Adults Using Multiple Inversion Time Arterial Spin Labeling MRI
C. Foster (2020)
Effect of Immobilization Acute Stress on Spatial Learning and Memory of Male Rats and Its Effect Moderation through Swimming
M. Ghorbani (2020)
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin (2019)
Deficiency of Soluble Epoxide Hydrolase Protects Cardiac Function Impaired by LPS-Induced Acute Inflammation
V. Samokhvalov (2019)
Complex I syndrome in striatum and frontal cortex in a rat model of Parkinson disease
L. Valdez (2019)
(+)-Catechin inhibits heart mitochondrial complex I and nitric oxide synthase: functional consequences on membrane potential and hydrogen peroxide production.
D. Iglesias (2019)
Sisyphus in Neverland
I. Ferrer (2018)
Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion
N. F. Marques (2018)
Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
S. L. Sison (2018)
Antioxidant properties of Calendula officinalis L. (Asteraceae) on Fe2+-initiated peroxidation of rat brain mitochondria
P. Zeinsteger (2018)
Docosahexaenoic acid protection in a rotenone induced Parkinson's model: Prevention of tubulin and synaptophysin loss, but no association with mitochondrial function
Norma Serrano-García (2018)
Oxicam-derived non-steroidal anti-inflammatory drugs suppress 1-methyl-4-phenyl pyridinium-induced cell death via repression of endoplasmic reticulum stress response and mitochondrial dysfunction in SH-SY5Y cells.
T. Omura (2018)
Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies
G. Santpere (2018)
The role of germline and somatic nuclear and mitochondrial DNA variation in neurodegenerative disorders
M. Keogh (2018)
Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia
P. Garcia‐Esparcia (2018)
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. Jellinger (2017)
Molecular mechanisms of autophagy and the effect of autophagy dysfunction on mitochondrial function
Elsje G. Otten (2017)
The role of TIGAR in Parkinson´s Disease
R. López (2017)
Age-related differences in stress response : Increase markers for oxidative stress and liver damage after heat stress in aged rats ?
M. Schenk (2017)
The Importance of Mitophagy in Maintaining Mitochondrial Function in U373MG Cells. Bafilomycin A1 Restores Aminochrome-Induced Mitochondrial Damage.
Sandro Huenchuguala (2017)
Salidroside Protects against MPP+-Induced Neuronal Injury through DJ-1-Nrf2 Antioxidant Pathway
Leitao Wu (2017)
Optic disc drusen
Nagham S Al-Zubidi (2017)
Hydrogen peroxide, nitric oxide and ATP are molecules involved in cardiac mitochondrial biogenesis in Diabetes.
Silvina S. Bombicino (2017)
Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
C. Guo (2017)
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
P. Garcia‐Esparcia (2017)See more